Diabetes, Vol 46, Issue 7 1230-1234, Copyright © 1997 by American Diabetes Association

ARTICLES

PPAR-gamma gene expression is elevated in skeletal muscle of obese and type II diabetic subjects

KS Park, TP Ciaraldi, L Abrams-Carter, S Mudaliar, SE Nikoulina and RR Henry
Department of Medicine, University of California at San Diego, La Jolla, USA.

The peroxisome proliferator activated receptor PPAR-gamma has been identified as a nuclear receptor for thiazolidenediones, which are compounds with insulin-sensitizing properties in several tissues, including skeletal muscle. To determine whether this receptor is expressed and possibly involved in insulin action/resistance in skeletal muscle, PPAR-gamma mRNA abundance and its regulation by insulin were quantified in muscle tissue and cultures from lean and obese nondiabetic and type II diabetic subjects using competitive reverse transcription-polymerase chain reaction (RT-PCR). In muscle biopsy specimens, PPAR-gamma mRNA was elevated in obese nondiabetic and type II diabetic subjects (23.4 +/- 4.2 and 28.0 +/- 5.69 x 10(3) copies/microg total RNA, respectively; both P < 0.05) compared with lean nondiabetic control subjects (9.4 +/- 2.3 x 10(3) copies/microg total RNA). Significant positive correlations were present among skeletal muscle PPAR-gamma mRNA levels, BMI (r = 0.67, P < 0.01), and fasting insulin concentration (r = 0.76, P < 0.001). PPAR-gamma mRNA levels were also elevated in muscle cultures from type II diabetic subjects compared with lean nondiabetic control subjects (330.1 +/- 52.9 vs. 192.1 +/- 27.0 x 10(3) copies/microg total RNA, P < 0.05). Insulin stimulation of muscle tissue (by hyperinsulinemic-euglycemic clamp for 3-4 h) or muscle cultures (30 nmol/l for 120 min) stimulated PPAR-gamma mRNA expression up to fourfold (10.0 +/- 2.7 to 41.3 +/- 7.4 x 10(3) copies/microg total RNA, P < 0.05, and 174.9 +/- 56.9 to 268.2 +/- 78.6 x 10(3) copies/microg total RNA, P < 0.05, respectively). In summary, PPAR-gamma mRNA expression in human skeletal muscle is acutely regulated by insulin and is increased in both obese nondiabetic and type II diabetic subjects in direct relation to BMI and fasting insulinemia. We conclude that abnormalities of PPAR-gamma may be involved in skeletal muscle insulin resistance of obesity and type II diabetes.
CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				V. A. Rodie, A. Young, F. Jordan, N. Sattar, I. A. Greer, and D. J. Freeman Human Placental Peroxisome Proliferator-Activated Receptor {delta} and {gamma} Expression in Healthy Pregnancy and in Preeclampsia and Intrauterine Growth Restriction Reproductive Sciences, July 1, 2005; 12(5): 320 - 329. [Abstract] [PDF]

				G. S. Kim, J. S. Hong, S. W. Kim, J.-M. Koh, C. S. An, J.-Y. Choi, and S.-L. Cheng Leptin Induces Apoptosis via ERK/cPLA2/Cytochrome c Pathway in Human Bone Marrow Stromal Cells J. Biol. Chem., June 6, 2003; 278(24): 21920 - 21929. [Abstract] [Full Text] [PDF]

				H. P. Koeffler Peroxisome Proliferator-activated Receptor {gamma} and Cancers Clin. Cancer Res., January 1, 2003; 9(1): 1 - 9. [Abstract] [Full Text] [PDF]

				H. G. Wahl, C. Kausch, F. Machicao, K. Rett, M. Stumvoll, and H.-U. Haring Troglitazone Downregulates {Delta}-6 Desaturase Gene Expression in Human Skeletal Muscle Cell Cultures Diabetes, April 1, 2002; 51(4): 1060 - 1065. [Abstract] [Full Text] [PDF]

				Q. N. Diep and E. L. Schiffrin Increased Expression of Peroxisome Proliferator-Activated Receptor-{alpha} and -{gamma} in Blood Vessels of Spontaneously Hypertensive Rats Hypertension, August 1, 2001; 38(2): 249 - 254. [Abstract] [Full Text] [PDF]

				A. Sugawara, K. Takeuchi, A. Uruno, Y. Ikeda, S. Arima, M. Kudo, K. Sato, Y. Taniyama, and S. Ito Transcriptional Suppression of Type 1 Angiotensin II Receptor Gene Expression by Peroxisome Proliferator-Activated Receptor-{{gamma}} in Vascular Smooth Muscle Cells Endocrinology, July 1, 2001; 142(7): 3125 - 3134. [Abstract] [Full Text] [PDF]

				S. Yonemitsu, H. Nishimura, M. Shintani, R. Inoue, Y. Yamamoto, H. Masuzaki, Y. Ogawa, K. Hosoda, G. Inoue, T. Hayashi, et al. Troglitazone Induces GLUT4 Translocation in L6 Myotubes Diabetes, May 1, 2001; 50(5): 1093 - 1101. [Abstract] [Full Text]

				K. Kasai, N. Banba, A. Hishinuma, M. Matsumura, H. Kakishita, M. Matsumura, S. Motohashi, N. Sato, and Y. Hattori 15-Deoxy-Delta 12,14-prostaglandin J2 facilitates thyroglobulin production by cultured human thyrocytes Am J Physiol Cell Physiol, December 1, 2000; 279(6): C1859 - C1869. [Abstract] [Full Text] [PDF]

				N. M. Lapsys, A. D. Kriketos, M. Lim-Fraser, A. M. Poynten, A. Lowy, S. M. Furler, D. J. Chisholm, and G. J. Cooney Expression of Genes Involved in Lipid Metabolism Correlate with Peroxisome Proliferator-Activated Receptor {gamma} Expression in Human Skeletal Muscle J. Clin. Endocrinol. Metab., November 1, 2000; 85(11): 4293 - 4297. [Abstract] [Full Text]

				E. Y. Oh, K. M. Min, J. H. Chung, Y.-K. Min, M.-S. Lee, K.-W. Kim, and M.-K. Lee Significance of Pro12Ala Mutation in Peroxisome Proliferator-Activated Receptor-{gamma}2 in Korean Diabetic and Obese Subjects J. Clin. Endocrinol. Metab., May 1, 2000; 85(5): 1801 - 1804. [Abstract] [Full Text]

				R. E. Law, S. Goetze, X.-P. Xi, S. Jackson, Y. Kawano, L. Demer, M. C. Fishbein, W. P. Meehan, and W. A. Hsueh Expression and Function of PPAR{gamma} in Rat and Human Vascular Smooth Muscle Cells Circulation, March 21, 2000; 101(11): 1311 - 1318. [Abstract] [Full Text] [PDF]

				M. R. Sartippour and G. Renier Differential Regulation of Macrophage Peroxisome Proliferator-Activated Receptor Expression by Glucose : Role of Peroxisome Proliferator-Activated Receptors in Lipoprotein Lipase Gene Expression Arterioscler. Thromb. Vasc. Biol., January 1, 2000; 20(1): 104 - 110. [Abstract] [Full Text] [PDF]

				R. C. Cooksey, L. F. Hebert Jr., J.-H. Zhu, P. Wofford, W. T. Garvey, and D. A. McClain Mechanism of Hexosamine-Induced Insulin Resistance in Transgenic Mice Overexpressing Glutamine:Fructose-6-Phosphate Amidotransferase: Decreased Glucose Transporter GLUT4 Translocation and Reversal by Treatment with Thiazolidinedione Endocrinology, March 1, 1999; 140(3): 1151 - 1157. [Abstract] [Full Text]

				M. J. Reginato, S. T. Bailey, S. L. Krakow, C. Minami, S. Ishii, H. Tanaka, and M. A. Lazar A Potent Antidiabetic Thiazolidinedione with Unique Peroxisome Proliferator-activated Receptor gamma -activating Properties J. Biol. Chem., December 4, 1998; 273(49): 32679 - 32684. [Abstract] [Full Text] [PDF]

				J. R. Zierath, J. W. Ryder, T. Doebber, J. Woods, M. Wu, J. Ventre, Z. Li, C. McCrary, J. Berger, B. Zhang, et al. Role of Skeletal Muscle in Thiazolidinedione Insulin Sensitizer (PPAR{gamma} Agonist) Action Endocrinology, December 1, 1998; 139(12): 5034 - 5041. [Abstract] [Full Text] [PDF]

				K. S. Park, T. P. Ciaraldi, K. Lindgren, L. Abrams-Carter, S. Mudaliar, S. E. Nikoulina, S. R. Tufari, J. H. Veerkamp, A. Vidal-Puig, and R. R. Henry Troglitazone Effects on Gene Expression in Human Skeletal Muscle of Type II Diabetes Involve Up-Regulation of Peroxisome Proliferator-Activated Receptor-{gamma} J. Clin. Endocrinol. Metab., August 1, 1998; 83(8): 2830 - 2835. [Abstract] [Full Text]

				K. S. Park, T. P. Ciaraldi, L. Abrams-Carter, S. Mudaliar, S. E. Nikoulina, and R. R. Henry Troglitazone Regulation of Glucose Metabolism in Human Skeletal Muscle Cultures from Obese Type II Diabetic Subjects J. Clin. Endocrinol. Metab., May 1, 1998; 83(5): 1636 - 1643. [Abstract] [Full Text]

				C. Mascaro, E. Acosta, J. A. Ortiz, P. F. Marrero, F. G. Hegardt, and D. Haro Control of Human Muscle-type Carnitine Palmitoyltransferase I Gene Transcription by Peroxisome Proliferator-activated Receptor J. Biol. Chem., April 10, 1998; 273(15): 8560 - 8563. [Abstract] [Full Text] [PDF]

				J. G. Hunter, M. F. van Delft, R. A. Rachubinski, and J. P. Capone Peroxisome Proliferator-activated Receptor gamma Ligands Differentially Modulate Muscle Cell Differentiation and MyoD Gene Expression via Peroxisome Proliferator-activated Receptor gamma -dependent and -independent Pathways J. Biol. Chem., October 5, 2001; 276(41): 38297 - 38306. [Abstract] [Full Text] [PDF]